SERINE PHOSPHORYLATION OF BIOSYNTHETIC PRO-UROKINASE FROM HUMAN TUMOR-CELLS

被引:12
作者
MASTRONICOLA, MR
STOPPELLI, MP
MIGLIACCIO, A
AURICCHIO, F
BLASI, F
机构
[1] UNIV COPENHAGEN,INST MIKROBIOL,BIOTECHNOL CTR MOLEC CELL BIOL,OSTER FARIMAGSGADE 2A,DK-1353 COPENHAGEN,DENMARK
[2] CNR,INT INST GENET & BIOPHYS,I-80125 NAPLES,ITALY
[3] FIRST MED SCH NAPLES,INST GEN PATHOL,NAPLES,ITALY
关键词
Metastasis; Phosphoserine; Plasminogen activator; Secretion;
D O I
10.1016/0014-5793(90)81519-T
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phosphorylation is a potent mechanism regulating the activity of many intracellular enzymes. We have discovered that the product of the human urokinase plasminogen activator gene, pro-uPA, is phosphorylated in serine in at least two human cell lines. Phosphorylation occurs within the cell during biosynthesis, and phosphorylated intracellular pro-uPA is secreted into the medium. Of the secreted pro-uPA molecules, 20-50% are phosphorylated in serine, thus representing a meaningful fraction of the total biosynthetic pro-uPA. Although the sites of phosphorylation have not yet been determined, at least two such sites must exist; in fact plasmin cleavage of phosphorylated single chain pro-uPA yields a two chain uPA in which both chains are phosphorylated. A specific function for pro-uPA phosphorylation has not yet been identified; however, it is tempting to speculate that, as in many other cases, phosphorylation may affect the activity of the enzyme, its response to inhibitors or the conversion of pro-uPA zymogen to active two-chain uPA. This would represent an additional way of regulating extracellular proteolysis, an important pathway involved in both intra- and extravascular phenomena like fibrinolysis, cell migration and invasiveness. © 1990.
引用
收藏
页码:109 / 114
页数:6
相关论文
共 36 条
[1]  
ANDREASEN PA, 1990, IN PRESS MOL CELL EN
[2]  
BALLOU LM, 1986, ENZYMES, V17, P311
[3]  
BLASI F, 1988, Fibrinolysis, V2, P73, DOI 10.1016/0268-9499(88)90370-0
[4]   UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - PROENZYME, RECEPTOR, AND INHIBITORS [J].
BLASI, F ;
VASSALLI, JD ;
DANO, K .
JOURNAL OF CELL BIOLOGY, 1987, 104 (04) :801-804
[5]  
BLASI F, 1990, IN PRESS GROWTH REGU
[6]   PROTEIN-PHOSPHORYLATION AND HORMONE ACTION [J].
COHEN, P .
PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1988, 234 (1275) :115-144
[7]  
CUBELLIS MV, 1986, J BIOL CHEM, V261, P5819
[8]   RECEPTOR-MEDIATED INTERNALIZATION AND DEGRADATION OF UROKINASE IS CAUSED BY ITS SPECIFIC INHIBITOR PAI-1 [J].
CUBELLIS, MV ;
WUN, TC ;
BLASI, F .
EMBO JOURNAL, 1990, 9 (04) :1079-1085
[9]   ACCESSIBILITY OF RECEPTOR-BOUND UROKINASE TO TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR [J].
CUBELLIS, MV ;
ANDREASEN, P ;
RAGNO, P ;
MAYER, M ;
DANO, K ;
BLASI, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (13) :4828-4832
[10]   PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER [J].
DANO, K ;
ANDREASEN, PA ;
GRONDAHLHANSEN, J ;
KRISTENSEN, P ;
NIELSEN, LS ;
SKRIVER, L .
ADVANCES IN CANCER RESEARCH, 1985, 44 :139-266